160 related articles for article (PubMed ID: 18723275)
1. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma.
Li L; Gao Y; Zhang L; Zeng J; He D; Sun Y
Cancer Lett; 2008 Dec; 272(1):61-9. PubMed ID: 18723275
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
3. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin.
Son YG; Kim EH; Kim JY; Kim SU; Kwon TK; Yoon AR; Yun CO; Choi KS
Cancer Res; 2007 Sep; 67(17):8274-84. PubMed ID: 17804742
[TBL] [Abstract][Full Text] [Related]
4. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
[TBL] [Abstract][Full Text] [Related]
5. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3.
Cheung CW; Vesey DA; Nicol DL; Johnson DW
BJU Int; 2007 Feb; 99(2):454-60. PubMed ID: 17313429
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
[TBL] [Abstract][Full Text] [Related]
8. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
Kim TH; Woo JS; Kim YK; Kim KH
J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
[TBL] [Abstract][Full Text] [Related]
9. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
10. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
[TBL] [Abstract][Full Text] [Related]
11. Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity.
Pook SH; Toh CK; Mahendran R
Cancer Lett; 2006 Jul; 238(1):146-52. PubMed ID: 16111802
[TBL] [Abstract][Full Text] [Related]
12. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine.
Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ
Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187
[TBL] [Abstract][Full Text] [Related]
13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
14. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.
Momeny M; Khorramizadeh MR; Ghaffari SH; Yousefi M; Yekaninejad MS; Esmaeili R; Jahanshiri Z; Nooridaloii MR
Eur J Pharmacol; 2008 Sep; 591(1-3):13-20. PubMed ID: 18599034
[TBL] [Abstract][Full Text] [Related]
15. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation.
Woo SM; Min KJ; Kim S; Park JW; Kim DE; Chun KS; Kim YH; Lee TJ; Kim SH; Choi YH; Chang JS; Kwon TK
Chem Biol Interact; 2014 Mar; 211():36-43. PubMed ID: 24440808
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer chemoprevention by silibinin: bench to bedside.
Singh RP; Agarwal R
Mol Carcinog; 2006 Jun; 45(6):436-42. PubMed ID: 16637061
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways.
Aisa Y; Miyakawa Y; Nakazato T; Shibata H; Saito K; Ikeda Y; Kizaki M
Am J Hematol; 2005 Jan; 78(1):7-14. PubMed ID: 15609279
[TBL] [Abstract][Full Text] [Related]
19. The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Oncol Rep; 2007 May; 17(5):1195-200. PubMed ID: 17390065
[TBL] [Abstract][Full Text] [Related]
20. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R
Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
